The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Endo International plc

  • ENDP
  • NASDAQ
  • Consumer Products
  • Latest 66.08
  • Currency US$
  • Change -0.22
  • Percent Change -0.332 %
  • Volume 266,936
  • Fri Jul 11, 2014 10:43 AM EDT NASDAQ data delayed 15 minutes.
  • Open 67.00
  • Previous Close 66.30
  • High 67.10
  • Low 66.02
  • Bidx2 66.06
  • Askx3 66.09
  • 52-week High03/04 82.16
  • 52-week Low08/07 36.175
  • Beta 1.68
  • Market Cap 7,640.17M
  • EPS -5.19
  • P/E
  • Forward P/E 16.13
  • PEG 1.85
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $2,661,020,000
  • Earnings $-1,137,600,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash $1,041,280,000
  • Current Ratio 1.38

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $9,527,960,000
  • Liabilities $6,490,600,000
  • Liabilities-to-Equity Ratio 2.14

Price Ratios

  • Price to Sales 2.87
  • Price to Book 2.52
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings May 1 $0.84 Aug 5 $0.89
Surprises May 1 9.52% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 11, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.

Related Securities
Symbol Type Latest % Chg

Officers

  • Roger H. Kimmel Chairman and Director
  • Rajiv De Silva Director; President and Chief
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

1400 ATWATER DRIVE
MALVERN, PA
19355

Phone: (484)-216-0000
Fax: (800)-3293636


www.endo.com

Ideas & Discussion

Live Discussion of ENDP on StockTwits